Number of the records: 1
Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment
SYS r040606 LBL ^^^^^naa^^22^^^^^^^^450^ 005 20130619105651.4 100 $a 20070228a2006 m y0sloc0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment $f P. Eriksson ... [et al.] 215 $c obr., tab. 320 $a Res. angl. 320 $a Bibliogr. odkazy 463 -1
$1 001 sllk_un_cat*sg000148_2006_006_004 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 53, no. 4 (2006), s. 285-290 $1 210 $a Bratislava $c VEDA, vydavateľstvo Slovenskej akadémie vied 541 1-
$a Úloha cirkulujúcich fragmentov cytokeratínu a angiogénnych faktorov u pacientov s nemalobunkovým nádorom pľúc IIIa-IIIb stupňa pri podaní plánovanej liečby $z slo 606 1-
$a karcinóm pľúc, nemalobunkový $x krv $x diagnostika $x terapia $2 mesh $3 sllk_un_auth*d002289 $9 . 606 1-
$a keratíny $2 mesh $3 sllk_un_auth*d007633 $9 . 606 1-
$3 sllk_un_auth*d014408 $a biomarkery nádorové $x analýza $9 . $2 M 606 2-
$a neovaskularizácia patologická $2 mesh $3 sllk_un_auth*d009389 $9 . 606 2-
$3 sllk_un_auth*d042442 $a faktory rastové endotelové cievne $9 . $2 mesh 606 2-
$a antigén tkanivový polypeptidový $2 M $3 sllk_un_auth*d019396 $9 . 606 2-
$a proteíny angiogénne $2 mesh $3 sllk_un_auth*d042501 $9 . 610 2-
$a cytokeratín 8 610 2-
$a cytokeratín 18 610 2-
$a cytokeratín 19 610 2-
$a angiogenéza 610 2-
$a VEGF 610 2-
$a bFGF 610 2-
$a MonoTotal 675 $a 616.24-006.6-07 $v 2. $z slo 701 -1
$a Eriksson $b P. $3 sllk_un_auth*p0047205 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Brattström $b D. $3 sllk_un_auth*p0047206 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Hesselius $b P. $3 sllk_un_auth*p0047207 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Larsson $b A. $3 sllk_un_auth*p0047208 $4 070 $p Department of Medical Sciences, Uppsala University Hospital, Sweden 701 -1
$a Bergström $b S. $3 sllk_un_auth*p0047209 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Ekman $b S. $3 sllk_un_auth*p0047210 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Goike $b H. $3 sllk_un_auth*p0047212 $4 070 $p IDL Biotech AB, Bromma, University Hospital of Huddinge, Sweden 701 -1
$a Wagenius $b G. $3 sllk_un_auth*p0047213 $4 070 $p Department of Oncology, University Hospital, Sweden 701 -1
$a Brodin $b O. $3 sllk_un_auth*p0047214 $4 070 $p Department of Oncology, University Hospital of Huddinge, Stockholm, Sweden 701 -1
$a Bergqvist $b M. $3 sllk_un_auth*p0047215 $4 070 $p Department of Oncology, University Hospital, Sweden 801 -0
$a SK $b BA006 $c 20070228 $g AACR2
Number of the records: 1